Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Меноррагии и внутриматочная гормональная рилизинг-система (в помощь практикующему врачу)
Меноррагии и внутриматочная гормональная рилизинг-система (в помощь практикующему врачу)
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В процессе развития внутриматочной контрацепции разработана гормональная внутриматочная рилизинг-система, которая сочетает в себе контрацептивные и лечебные свойства, в частности, при меноррагиях.
Ключевые слова: внутриматочная гормональная система Мирена, меноррагии, анемия.
Key words: hormone intrauterine system Mirena, menorrhagiae, anemia.
Ключевые слова: внутриматочная гормональная система Мирена, меноррагии, анемия.
________________________________________________
Key words: hormone intrauterine system Mirena, menorrhagiae, anemia.
Полный текст
Список литературы
1. Chattopdhyay B, Nigam A, Goswami S, Chakravarty PS. Clinical outcome of levonorgestrel intra-uterine system in idiopathic menorrhagia. Source Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi, India. Eur Rev Med Pharmacol Sci 2011; 15 (7): 764–8.
2. Прилепская В.Н., Назарова Н.М. Новые технологии в контрацепции: гормональные рилизинг-системы. Гинекология, 2005; 1 (7).
3. Treffers, PE Breastfeeding duration related to practise contraception in the Netherlands 2009. Foundation Acta Pædiatrica.
4. Прилепская В.Н., Межевитинова Е.А. Гормональная контрацепция, 2011; с. 156–8.
5. Rauramo et al Intrauterine Therapy of Menorrhagia Obstetric and Gynecology 2004; 104 (6).
6. Критерии приемлемости использования методов контрацепции. ВОЗ. 2009.
7. Guidance on contraception for women aged over 40 years: response from the CEU.
8. Guidelines National Institute for Health and Clinical Excellence 2007.
9. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
10. Прилепская В.Н. Руководство по контрацепции. МЕДпресс-информ, М.: 2010; с. 250.
11. Endrikat J, Vilos G, Muysers C et al. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Epub ahead of print. Arch Gynecol Obstet 2011; 8.
12. Perception of oral contraceptives among women of reproductive age in Japan: A comparison with the USA and France.
13. Bastianelli C, Farris M, Rapiti S. Mirena, an Italian experience. Department of Obstetrics and Gynecology, La Sapienza University, Rome, Italy 2011; 63 (4): 343–9.
14. Tariq N, Ayub R, Jaffery T et al. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception. J Coll Physicians Surg Pak 2011; 21 (4): 210–3.
15. Chi C, Huq FY, Kadir RA. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up. Contraception 2011; 83 (3): 242–7. Epub 2010; Aug 30.
16. Ghazizadeh S, Bakhtiari F, Rahmanpour H et al. A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia 2011; 3: 207–11. Epub 2011 Jul 20.
17. Erian M, McLaren G, Baartz D. The wandering Mirena: laparoscopic retrieval. JSLS 2011; 15 (1): 127–30.
18. Pattison H, Daniels J, Kai J, Gupta J The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis. BJOG 2011; 118 (12): 1528–31. doi: 10.1111/j.1471-0528.2011.03057.x. Epub 2011 Jul 27.
19. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia, PA, USA. Lippincott Williams&Wilkins 2005; p. 559.
20. Shaaban MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception 2011; 83 (1): 48–54. Epub 2010 Aug 7.
2. Прилепская В.Н., Назарова Н.М. Новые технологии в контрацепции: гормональные рилизинг-системы. Гинекология, 2005; 1 (7).
3. Treffers, PE Breastfeeding duration related to practise contraception in the Netherlands 2009. Foundation Acta Pædiatrica.
4. Прилепская В.Н., Межевитинова Е.А. Гормональная контрацепция, 2011; с. 156–8.
5. Rauramo et al Intrauterine Therapy of Menorrhagia Obstetric and Gynecology 2004; 104 (6).
6. Критерии приемлемости использования методов контрацепции. ВОЗ. 2009.
7. Guidance on contraception for women aged over 40 years: response from the CEU.
8. Guidelines National Institute for Health and Clinical Excellence 2007.
9. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
10. Прилепская В.Н. Руководство по контрацепции. МЕДпресс-информ, М.: 2010; с. 250.
11. Endrikat J, Vilos G, Muysers C et al. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Epub ahead of print. Arch Gynecol Obstet 2011; 8.
12. Perception of oral contraceptives among women of reproductive age in Japan: A comparison with the USA and France.
13. Bastianelli C, Farris M, Rapiti S. Mirena, an Italian experience. Department of Obstetrics and Gynecology, La Sapienza University, Rome, Italy 2011; 63 (4): 343–9.
14. Tariq N, Ayub R, Jaffery T et al. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception. J Coll Physicians Surg Pak 2011; 21 (4): 210–3.
15. Chi C, Huq FY, Kadir RA. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up. Contraception 2011; 83 (3): 242–7. Epub 2010; Aug 30.
16. Ghazizadeh S, Bakhtiari F, Rahmanpour H et al. A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia 2011; 3: 207–11. Epub 2011 Jul 20.
17. Erian M, McLaren G, Baartz D. The wandering Mirena: laparoscopic retrieval. JSLS 2011; 15 (1): 127–30.
18. Pattison H, Daniels J, Kai J, Gupta J The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis. BJOG 2011; 118 (12): 1528–31. doi: 10.1111/j.1471-0528.2011.03057.x. Epub 2011 Jul 27.
19. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia, PA, USA. Lippincott Williams&Wilkins 2005; p. 559.
20. Shaaban MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception 2011; 83 (1): 48–54. Epub 2010 Aug 7.
2. Прилепская В.Н., Назарова Н.М. Новые технологии в контрацепции: гормональные рилизинг-системы. Гинекология, 2005; 1 (7).
3. Treffers, PE Breastfeeding duration related to practise contraception in the Netherlands 2009. Foundation Acta Pædiatrica.
4. Прилепская В.Н., Межевитинова Е.А. Гормональная контрацепция, 2011; с. 156–8.
5. Rauramo et al Intrauterine Therapy of Menorrhagia Obstetric and Gynecology 2004; 104 (6).
6. Критерии приемлемости использования методов контрацепции. ВОЗ. 2009.
7. Guidance on contraception for women aged over 40 years: response from the CEU.
8. Guidelines National Institute for Health and Clinical Excellence 2007.
9. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
10. Прилепская В.Н. Руководство по контрацепции. МЕДпресс-информ, М.: 2010; с. 250.
11. Endrikat J, Vilos G, Muysers C et al. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Epub ahead of print. Arch Gynecol Obstet 2011; 8.
12. Perception of oral contraceptives among women of reproductive age in Japan: A comparison with the USA and France.
13. Bastianelli C, Farris M, Rapiti S. Mirena, an Italian experience. Department of Obstetrics and Gynecology, La Sapienza University, Rome, Italy 2011; 63 (4): 343–9.
14. Tariq N, Ayub R, Jaffery T et al. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception. J Coll Physicians Surg Pak 2011; 21 (4): 210–3.
15. Chi C, Huq FY, Kadir RA. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up. Contraception 2011; 83 (3): 242–7. Epub 2010; Aug 30.
16. Ghazizadeh S, Bakhtiari F, Rahmanpour H et al. A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia 2011; 3: 207–11. Epub 2011 Jul 20.
17. Erian M, McLaren G, Baartz D. The wandering Mirena: laparoscopic retrieval. JSLS 2011; 15 (1): 127–30.
18. Pattison H, Daniels J, Kai J, Gupta J The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis. BJOG 2011; 118 (12): 1528–31. doi: 10.1111/j.1471-0528.2011.03057.x. Epub 2011 Jul 27.
19. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia, PA, USA. Lippincott Williams&Wilkins 2005; p. 559.
20. Shaaban MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception 2011; 83 (1): 48–54. Epub 2010 Aug 7.
________________________________________________
2. Прилепская В.Н., Назарова Н.М. Новые технологии в контрацепции: гормональные рилизинг-системы. Гинекология, 2005; 1 (7).
3. Treffers, PE Breastfeeding duration related to practise contraception in the Netherlands 2009. Foundation Acta Pædiatrica.
4. Прилепская В.Н., Межевитинова Е.А. Гормональная контрацепция, 2011; с. 156–8.
5. Rauramo et al Intrauterine Therapy of Menorrhagia Obstetric and Gynecology 2004; 104 (6).
6. Критерии приемлемости использования методов контрацепции. ВОЗ. 2009.
7. Guidance on contraception for women aged over 40 years: response from the CEU.
8. Guidelines National Institute for Health and Clinical Excellence 2007.
9. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
10. Прилепская В.Н. Руководство по контрацепции. МЕДпресс-информ, М.: 2010; с. 250.
11. Endrikat J, Vilos G, Muysers C et al. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Epub ahead of print. Arch Gynecol Obstet 2011; 8.
12. Perception of oral contraceptives among women of reproductive age in Japan: A comparison with the USA and France.
13. Bastianelli C, Farris M, Rapiti S. Mirena, an Italian experience. Department of Obstetrics and Gynecology, La Sapienza University, Rome, Italy 2011; 63 (4): 343–9.
14. Tariq N, Ayub R, Jaffery T et al. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception. J Coll Physicians Surg Pak 2011; 21 (4): 210–3.
15. Chi C, Huq FY, Kadir RA. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up. Contraception 2011; 83 (3): 242–7. Epub 2010; Aug 30.
16. Ghazizadeh S, Bakhtiari F, Rahmanpour H et al. A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia 2011; 3: 207–11. Epub 2011 Jul 20.
17. Erian M, McLaren G, Baartz D. The wandering Mirena: laparoscopic retrieval. JSLS 2011; 15 (1): 127–30.
18. Pattison H, Daniels J, Kai J, Gupta J The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis. BJOG 2011; 118 (12): 1528–31. doi: 10.1111/j.1471-0528.2011.03057.x. Epub 2011 Jul 27.
19. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia, PA, USA. Lippincott Williams&Wilkins 2005; p. 559.
20. Shaaban MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception 2011; 83 (1): 48–54. Epub 2010 Aug 7.
Авторы
В.Н.Прилепская, А.Б.Летуновская
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздравсоцразвития РФ
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздравсоцразвития РФ
________________________________________________
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.